
Teladoc (TDOC) Stock Forecast & Price Target
Teladoc (TDOC) Analyst Ratings
Bulls say
Teladoc Health, Inc. has set a strong financial outlook with projected Integrated Care revenue of $1,613.6 million for CY26, reflecting a year-over-year increase of $34.0 million. The company anticipates significant growth in its BetterHelp segment, with insurance revenue expected to rise from $13.0 million in CY25 to between $75.0 million and $90.0 million in CY26, increasing its revenue mix from 1.4% to 9.0%. Additionally, the Integrated Care segment's adjusted EBITDA is anticipated to reach $251.9 million, an increase of $12.6 million year-over-year, highlighting the company's strong position in the virtual healthcare market and its capacity for growth moving forward.
Bears say
The analysis of Teladoc Health Inc reveals a significant decline in the growth trajectory of its BetterHelp segment, with management forecasting low-single-digit growth over the next three years, a stark contrast to prior performance levels. The anticipated reduction in membership and the transition from fee-based to visit-based revenue models within the Integrated Care segment contribute to heightened financial uncertainty, further exacerbated by expected decreases in customer enrollment due to expiring ACA subsidies. Additionally, operational expenditure cuts aimed at maintaining profitability may compromise key functions, diminish the company's value proposition, and weaken pricing power, all of which could hinder future growth prospects.
This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.
Teladoc (TDOC) Analyst Forecast & Price Prediction
Start investing in Teladoc (TDOC)
Order type
Buy in
Order amount
Est. shares
0 shares